Get answers to your health questions and concerns. It's easy to be part of our live chat events, led by Cleveland Clinic physicians and health professionals.
Upcoming Health Chats
Tuesday, May 2, 2017 - 12 Noon
The Miller Family Heart & Vascular Institute at Cleveland Clinic has earned an international reputation for excellence in patient care, surgical results, and clinical research. We have physicians who specialize in the diagnosis and management of vascular disease, including rare disorders such as May-Thurner syndrome (MTS), Klippel-Trenaunay (K-T) syndrome, median arcuate ligament syndrome, vascular issues affecting athletes such as cyclist induced iliac endofibrosis, congenital vascular defects, and others. Take advantage of this opportunity to chat live about May-Thurner syndrome and other rare disorders with cardiologist Deborah Hornacek, MD, and vascular surgeon W. Michael Park, MD.
Wednesday, May 10, 2017 - 12 Noon
Current treatments for cancer have been one of the greatest achievements in modern medicine. However, many of the cancer therapies can have significant and serious cardiovascular side effects, such as heart failure, thromboembolism, severe hypertension and lethal arrhythmia if not managed properly. The risks and side effects can interrupt the cancer treatment, or may not even show up until years later. Therefore, minimizing cardiovascular risk factors, such as smoking and blood pressure, and watching out for early symptoms are even more essential for cancer survivors. It’s also important to work with a multi-disciplinary team of experts including oncologists and cardiologists who work together to help minimize the impact of chemo and radiation on your heart before, during, and after your treatments. Take this opportunity to learn more and have your questions answered by Co-Director of Cleveland Clinic’s Cardio-Oncology Center, Patrick Collier, MD, PhD, and cardiologist in the Section of Cardiovascular Imaging in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Milind Desai, MD.